Ran Zheng
Fortuna: - $ al 31/08/2026
Fortuna: - $ al 31/08/2026
Ran Zheng is currently an Independent Director at Caribou Biosciences, Inc. since 2021.
Former roles include Chief Executive Officer & Director at Landmark Bio PBLLC from 2021 to 2025, Vice President-Development Supply Chain at Amgen, Inc., and Chief Technical Officer at Orchard Therapeutics Plc from 2019 to 2021.
Education includes graduate studies at the University of Minnesota and undergraduate studies at Beijing Forestry University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Director/Miembro de la Junta | 24/09/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
Landmark Bio PBLLC
Landmark Bio PBLLC BiotechnologyHealth Technology Manufactures and develops cell & gene therapy products | Director Ejecutivo | 01/01/2025 |
| ORCHARD THERAPEUTICS PLC | Director Técnico/Científico/I+D | 01/02/2021 |
| AMGEN INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Caribou Biosciences, Inc.
Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beijing Forestry University
Beijing Forestry University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Landmark Bio PBLLC
Landmark Bio PBLLC BiotechnologyHealth Technology Manufactures and develops cell & gene therapy products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.